Determining measles-containing vaccine demand and supply: An imperative to support measles mortality reduction efforts

Journal of Infectious Diseases

Volumn 187, Issue SUPPL. 1, 2003, Pages

  Costa, Alejandro ^a   Henao Restrepo, Ana Maria ^a   Hall, Shanelle Marie ^b   Jarrett, Stephen ^c   Hoekstra, Edward John ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b U Nations Children's F   (Denmark)

^c UNICEF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

DRUG COST; DRUG MANUFACTURE; HEALTH CARE PLANNING; HUMAN; MEASLES; MEASLES VACCINATION; MORTALITY; PRIORITY JOURNAL; REVIEW; UNITED NATIONS; UNITED NATIONS CHILDREN EMERGENCY FUND; WORLD HEALTH ORGANIZATION;

CHILD, PRESCHOOL; FORECASTING; HUMANS; INFANT; MASS IMMUNIZATION; MEASLES; MEASLES VACCINE; UNITED NATIONS; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 0038324065     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368274     Document Type: Review

References (16)

1. World Health Organization. The world health report 2001. Mental health: new understanding, new hope. Geneva: WHO, 2001.
2. UNICEF. Vaccine security: ensuring a sustained, uninterrupted supply of affordable vaccines. New York: UNICEF, 2001 (E/ICEF/2002/6).
3. World Health Organization. WHO vaccine-preventable diseases: monitoring system: 2001 global summary. Geneva: WHO, 2001 (WHO/V&B/01.34).
4. World Health Organization, Expanded programme on immunization. Measles control in the 1990s: plan of action for global measles control. Geneva: WHO, 1992 (WHO/EPI/GEN/92.3).
5. de Quadros CA, Olivé JM, Hersh BS, et al. Measles elimination in the Americas: evolving strategies. JAMA 1996; 275:224-9.
6. World Health Organization. Global measles mortality reduction and regional elimination, 2000-2001. Part II. Wkly Epidemiol Rec 2002; 77:58-61.
7. World Health Organization. Strategies for reducing global measles mortality. Wkly Epidemiol Rec 2000; 75:411-6.
8. World Health Organization-UNICEF. Strategic plan for measles mortality reduction and regional elimination 2001-2005. Geneva: WHO, 2001 (WHO/V&B/01.13).
9. World Health Organization. Preventing congenital rubella syndrome. Wkly Epidemiol Rec 2000; 75:290-5.
10. Castillo-Solorzano C, de Quadros CA. Rubella in the Americas region [in Spanish]. Rev Panam Salud Pública 2002; 11:273-6.
11. Greco M. The future of vaccines: an industrial perspective. Vaccine 2001; 20(Suppl 1):S101-3.
12. Greco M. Key drivers behind the development of global vaccine market. Vaccine 2001; 19:1606-10.
13. Vandersmissen W. WHO expectation and industry goals. Vaccine 2001; 19:1611-5.
14. Anonymous. Time to look beyond MMR in autism research. Lancet 2002; 359:637.
15. McKinney SL, Milstien JB. Issues in vaccine selection: a case study of DTwP-based combination vaccines. In: Agenda and abstracts of the Strategic Advisory Group of Experts. Geneva: WHO Department of Vaccines and Biologicals, 2002.
16. World Health Organization, Department of Vaccines and Biologicals. Report of a meeting with measles vaccine manufacturers on projected demand. In: Report of meeting with measles vaccine manufacturers on projected demand, 2001. Geneva: WHO, 2002.